• Addressing and sustaining human capital development for health through professional development in Qatar 

      Aboulsoud, Samar (2018 , Presentation)
      Outline: * Qatar Council for Healthcare Practitioners (QCHP) * QATAR VISION 2030 * National Health Strategy 2018-2022 *National CME/CPD Program in Numbers
    • Generic Medicines: the big picture 

      Hassali, Mohamed Azmi Ahmad (2018 , Presentation)
      Outline: * BACKGROUND & INTRODUCTION * HEALTHCARE EXPENDITURE * ROLE OF GENERIC- MEDICINES IN HEALTH - CARE SYSTEM * GLOBAL SCENARIO * MALAYSIAN SCENARIO
    • Intellectual Property, Technology Transfer, and Local Production to Increase Access to Medicines 

      KATSIOLOUDES, MARIOS I. (2018 , Presentation)
      Outlines: * INTELLECTUAL PROPERTY (IP): THE CONCEPT *QATAR and IP * WIPO *QATAR’S OTHER MEMBERSHIPS *Patent Cooperation Treaty *INTELLECTUAL PROPERTY LAWS OF QATAR * TECHNOLOGY TRANSFER (TT) IN THE PHARMACEUTICAL ...
    • Managing the Impact of Blockade on Qatar's Aggregate Business 

      Al-Suwaidi, Ahmed Abdulla (2018 , Presentation)
      *QPMC was founded in 2006 on the instruction of the Qatari Government. *QPMC is at the forefront of facilitating the construction boom in Qatar. *The company stands for quality, reliability and efficiency. *QPMC is ...
    • Pharmaceutical Industry in Qatar 

      Al-Mohannadi, Ahmed (2018 , Presentation)
      Overview: * Current Pharma Market Share of Qatar * Consequences of depending on other countries * Main challenges and barriers of local production of medicines in Qatar * How to overcome the challenges and barriers * ...
    • Qatar Rail – Doha Metro 

      Khalid, Al-Thani (2018 , Presentation)
      About Qatar Rail: *Following its establishment in 2011, Qatar Rail is leading one of the largest rail projects in the world to meet the demands of Qatar’s growing population. *The company is responsible for the design, ...
    • WHO Model List Of Essential Medicines and countries Health response during Embargo 

      Alhajri, Mohd (2018 , Presentation)
      Outline: A. Challenges and barriers to medicines availability in crisis. B. Access to domestic and global market of generic medicines. C. WHO Model List Of Essential Medicines. D. Case example and the way forward from ...